Page 1 | Search Results | Blood | American Society of Hematology

1-11 of 11

Sort by

Sort Order Select

Journal Articles

Durable Responses and Survival in High Risk AML and MDS Patients Treated with an Allogeneic Leukemia-Derived Dendritic Cell Vaccine

Luca L.G. Janssen, MD, Theresia M. Westers, PhD, Jeroen Rovers, MD PhD, Peter Valk, PhD, Jacqueline Cloos, PhD, Tanja D. de Gruijl, PhD, Arjan A. Van de Loosdrecht, MD PhD

Blood (2019) 134 (Supplement_1): 1381.

https://doi.org/10.1182/blood-2019-127881

Published: 2019

Journal Articles

CD141 Expressing Monocytes Show an Inflammatory Profile and Are Associated with Low-Risk Features in Myelodysplastic Syndromes

Nathalie van Leeuwen-Kerkhoff, MD, Theresia M. Westers, PhD, Shahram Kordasti, MD PhD, Tanja D. de Gruijl, PhD, Arjan A. van de Loosdrecht, MD PhD

Blood (2016) 128 (22): 4298.

https://doi.org/10.1182/blood.V128.22.4298.4298

Published: 2016

Journal Articles

Dendritic Cell Subsets in Bone Marrow and Peripheral Blood of Patients with Myelodysplastic Syndromes Display Numeric and Functional Defects

Nathalie van Leeuwen-Kerkhoff, MD, Theresia M. Westers, PhD, Hetty J Bontkes, PhD, Shahram Kordasti, MD PhD, Ghulam J. Mufti, MD PhD, Tanja D de Gruijl, PhD, Arjan A van de Loosdrecht, MD PhD

Blood (2015) 126 (23): 4109.

https://doi.org/10.1182/blood.V126.23.4109.4109

Published: 2015

Journal Articles

Chronic Lymphocytic Leukemia (CLL) Cells Are Susceptible to γδ-T Cell Mediated Killing, Provided CLL-Derived γδ-T Cell Dysfunction Can be Reversed

Iris de Weerdt, Sanne Terpstra, Tom Hofland, Roeland Lameris, MD, Renee C.G. de Bruin, Mark-David Levin, MDPhD, Ester B.M. Remmerswaal, PhD, Ineke J.M. ten Berge, MD PhD, Sanne H. Tonino, MD PhD, Tanja D de Gruijl, PhD, Hans van der Vliet, MD PhD, Arnon P. Kater, MD PhD

Blood (2015) 126 (23): 2914.

https://doi.org/10.1182/blood.V126.23.2914.2914

Published: 2015

Journal Articles

Clinical and Immunological Results Of a Phase I/IIa Study Of Allogeneic Dendritic Cell (DC) Vaccination, An “off The shelf” Treatment To Prevent Or Delay Relapse In Elderly Patients With Acute Myeloid Leukemia

Arjan A van de Loosdrecht, MD, PhD, Sandra van Wetering, PhD, Saskia Santegoeds, Satwinder Kaur Singh, PhD, Malika Koppes, Anthony Hall, MD, Ada M. Kruisbeek, PhD, Tanja D. de Gruijl, PhD., Gert J. Ossenkoppele, MD PhD

Blood (2013) 122 (21): 2651.

https://doi.org/10.1182/blood.V122.21.2651.2651

Published: 2013

Journal Articles

Expansion of AML Blasts Induces CD14 Expression and Facilitates Leukemic DC Development for Therapeutic Application In AML

Willemijn van den Ancker, Pepijn G.J.T.B. Wijnands, Theresia M. Westers, PhD, Hetty J. Bontkes, PhD, Sandra van Wetering, PhD, Ada M. Kruisbeek, PhD, Gert J. Ossenkoppele, MD, PhD, Tanja D. de Gruijl, PhD., Arjan A. Van de Loosdrecht, MD, PhD

Blood (2010) 116 (21): 2193.

https://doi.org/10.1182/blood.V116.21.2193.2193

Published: 2010

Journal Articles

Apoptotic Blebs From Leukemic Cells as a Source of Tumor Associated Antigen for Monocyte-Derived Dendritic Cell Loading

Jurjen M Ruben, MSc, Hetty J Bontkes, PhD, Theresia M. Westers, PhD, Willemijn van Den Ancker, MSc, Gert J. Ossenkoppele, MD, PhD, Tanja D de Gruijl, PhD, Arjan A. Van de Loosdrecht, MD, PhD

Blood (2010) 116 (21): 3283.

https://doi.org/10.1182/blood.V116.21.3283.3283

Published: 2010

Journal Articles

Functional PRAME Specific T Cells Can Be Cultured From CD8+ Cells From Healthy Donors but Not From Patients at First CR: Implications for Immunotherapeutic Strategies in AML.

Willemijn van den Ancker, Theresia M Westers, PhD, Hetty J Bontkes, PhD, Dewi Wulandari, Erik Hooijberg, PhD, Anita GM Stam, Saskia JAM Santegoets, PhD, Gert J Ossenkoppele, MD, PhD, Tanja D de Gruijl, PhD, Arjan A van de Loosdrecht, MD, PhD

Blood (2009) 114 (22): 4139.

https://doi.org/10.1182/blood.V114.22.4139.4139

Published: 2009

Journal Articles

Maturation by Toll Like Receptor Ligand R848 Improves the Uptake of Apoptotic Leukemic Cells by Monocyte Derived Dendritic Cells.

Willemijn van den Ancker, Theresia M Westers, PhD, Hetty J Bontkes, PhD, Tanja D de Gruijl, PhD, Gert J Ossenkoppele, MD, PhD, Arjan A van de Loosdrecht, MD, PhD

Blood (2009) 114 (22): 2075.

https://doi.org/10.1182/blood.V114.22.2075.2075

Published: 2009

Journal Articles

Comparative Analysis of CD8 + t Cell Priming Efficiencies against a Panel of Leukemia-Associated HLA-A2 Restricted Epitopes Identifies PRAME as a Possible Vaccination Target in AML

Willemijn van den Ancker, Theresia M Westers, PhD, Hetty J Bontkes, PhD, Erik Hooijberg, PhD, Anita GM Stam, Saskia JAM Santegoets, PhD, Gert J Ossenkoppele, MD, PhD, Tanja D de Gruijl, PhD, Arjan A van de Loosdrecht, MD, PhD

Blood (2008) 112 (11): 5441.

https://doi.org/10.1182/blood.V112.11.5441.5441

Published: 2008

Journal Articles

The Novel Bispecific Diabody αCD40/αCD28 Strengthens Leukemic Dendritic Cell Induced T Cell Reactivity.

Ilse Houtenbos, MD, Saskia J.A.M. Santegoets, Theresia M. Westers, PhD, Quinten Waisfisz, PhD, Sergey Kipriyanov, PhD, Fedor Denkers, Rik J. Scheper, Tanja D. de Gruijl, PhD, Gert Ossenkoppele, Arjan A. van Loosdrecht, MD, PhD

Blood (2006) 108 (11): 3710.

https://doi.org/10.1182/blood.V108.11.3710.3710

Published: 2006

NARROW

Durable Responses and Survival in High Risk AML and MDS Patients Treated with an Allogeneic Leukemia-Derived Dendritic Cell Vaccine

CD141 Expressing Monocytes Show an Inflammatory Profile and Are Associated with Low-Risk Features in Myelodysplastic Syndromes

Dendritic Cell Subsets in Bone Marrow and Peripheral Blood of Patients with Myelodysplastic Syndromes Display Numeric and Functional Defects

Chronic Lymphocytic Leukemia (CLL) Cells Are Susceptible to γδ-T Cell Mediated Killing, Provided CLL-Derived γδ-T Cell Dysfunction Can be Reversed

Clinical and Immunological Results Of a Phase I/IIa Study Of Allogeneic Dendritic Cell (DC) Vaccination, An “off The shelf” Treatment To Prevent Or Delay Relapse In Elderly Patients With Acute Myeloid Leukemia

Expansion of AML Blasts Induces CD14 Expression and Facilitates Leukemic DC Development for Therapeutic Application In AML

Apoptotic Blebs From Leukemic Cells as a Source of Tumor Associated Antigen for Monocyte-Derived Dendritic Cell Loading

Functional PRAME Specific T Cells Can Be Cultured From CD8+ Cells From Healthy Donors but Not From Patients at First CR: Implications for Immunotherapeutic Strategies in AML.

Maturation by Toll Like Receptor Ligand R848 Improves the Uptake of Apoptotic Leukemic Cells by Monocyte Derived Dendritic Cells.

Comparative Analysis of CD8 + t Cell Priming Efficiencies against a Panel of Leukemia-Associated HLA-A2 Restricted Epitopes Identifies PRAME as a Possible Vaccination Target in AML

The Novel Bispecific Diabody αCD40/αCD28 Strengthens Leukemic Dendritic Cell Induced T Cell Reactivity.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only